Skip to main content
Clinical Trials/IRCT2014020216453N1
IRCT2014020216453N1CompletedPhase 2

Evaluation of the effect of progesterone on latency period of preterm premature rupture of membrane in 24-34 weeks of gestation

Research chancelor of kerman University of Medical Sciences0 sites171 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
171

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
15 years to 45 years (—)
Sex
Female

Inclusion Criteria

  • obvious fluid passage or direct observation with speculum or by positive nitrazine test in gestational age of 24 to 34 week - according to first trimester sonography or last menstrual period.
  • Exclusion criteria: anomalous fetus? multiple gestation? chorioamnionitis signs at the time of admission? fetal distress? abruptio placenta? placenta previa? IUGR? medical diseases of mother (DM, severe preeclampsia).

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Research chancelor of kerman University of Medical Sciences

Similar Trials